top of page

Pharma

Placeholder Image

Chipscreen NewWay Biosciences Initiates Phase I Clinical Trial

First advanced solid tumour patient dosed in a phase I clinical trial assessing preliminary efficacy of bispecific antibody, NWY001.

Read More
bottom of page